GlassScriptPhysician profile
David Alexander Porter
NPI 1871859371
$63,475.30
in general payments reported to CMS, 2019-2025
20 companies · $21K in 2025
The $21K reported for 2025 was more than what 91% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,804 · 2020: $1,226 · 2021: $2,243 · 2022: $458 · 2023: $1,941 · 2024: $32K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $47K · Food and Beverage: $4,617 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,375 · Travel and Lodging: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $46,500.00 |
| Food and Beverage | $4,617.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,375.00 |
| Travel and Lodging | $1,253.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $52,274.57 | 2021-2025 | Integrity, Integrity Implant, Revomotion |
| Seapearl East, INC | $4,401.66 | 2019-2023 | |
| Arthrosurface Incorporated | $1,971.80 | 2019-2025 | |
| Stryker Corporation | $1,857.17 | 2019-2025 | Mako, Cinchlock, Samurai |
| Depuy Synthes Sales INC. | $1,279.36 | 2019-2025 | Lupine Orthocord, N/A, Milagro |
| Royal Biologics, INC. | $401.39 | 2020-2024 | |
| Highridge Medical LLC | $258.49 | 2024-2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Zimvie INC. | $246.57 | 2022-2023 | |
| Smith+Nephew, INC. | $170.52 | 2020-2025 | Double Pump Rf, N/A, Lens 4k |
| Ossio INC | $165.38 | 2023 | |
| Medical Device Business Services, INC. | $120.53 | 2023 | Fms |
| Zimmer Biomet Holdings, INC. | $107.89 | 2022-2023 | Tapestry |
| Sumitomo Pharma America, INC. | $54.21 | 2024-2025 | Gemtesa |
| Kci USA, INC. | $50.58 | 2021 | |
| Pacira Therapeutics, INC. | $28.85 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heraeus Medical, LLC. | $25.58 | 2021 | |
| Fidia Pharma USA INC. | $16.55 | 2019 | |
| Next Science LLC | $15.67 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.48 | 2019 | |
| Orthogenrx INC. | $14.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.